Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 50228-423

7 FDA label images from Sciegen Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 50228-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 30ct (Ranolazine 1000mg 30tab)

Package Label – Ranolazine, 1000mg Bottle, 30ct (Ranolazine 1000mg 30tab)
Label for Ranolazine Extended-Release Tablets, 1,000 mg strength, oral extended-release film-coated tablets by ScieGen Pharmaceuticals, Inc. The label indicates a package size of 30 tablets, includes dosage form and storage instructions, and displays the NDC 50228-424-30 along with a barcode and manufacturer details.*
FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 500ct (Ranolazine 1000mg 500tab)

Package Label – Ranolazine, 1000mg Bottle, 500ct (Ranolazine 1000mg 500tab)
Label for Ranolazine Extended-Release Tablets 1000 mg from ScieGen Pharmaceuticals, Inc. The label indicates storage instructions, dosage information, and the quantity of 500 tablets. It includes a barcode and the note 'Rx Only.' There is also a prominent yellow box highlighting the 1000 mg strength and a side label stating 'NO VARNISH.'*
FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 60ct (Ranolazine 1000mg 60tab)

Package Label – Ranolazine, 1000mg Bottle, 60ct (Ranolazine 1000mg 60tab)
Label for Ranolazine Extended-Release Tablets 1,000 mg by ScieGen Pharmaceuticals, Inc. The film-coated oral tablets are supplied in a package of 60 tablets. The label includes storage instructions, dosage advisories, and a barcode.*
FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 30ct (Ranolazine 500mg 30tab)

Package Label – Ranolazine, 500mg Bottle, 30ct (Ranolazine 500mg 30tab)
Ranolazine Extended-Release Tablets 500 mg film-coated tablets label. The label states the strength as 500 mg per tablet and indicates a package size of 30 tablets. The product is manufactured by ScieGen Pharmaceuticals, Inc. Storage instructions and a barcode are also visible. The label denotes the product as Rx only.*
FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 500ct (Ranolazine 500mg 500tab)

Package Label – Ranolazine, 500mg Bottle, 500ct (Ranolazine 500mg 500tab)
Label for Ranolazine Extended-Release Tablets 500 mg, a film-coated, extended-release oral tablet by ScieGen Pharmaceuticals, Inc. The label specifies each tablet contains 500 mg of ranolazine and includes storage instructions, dosage note, and packaging size of 500 tablets. It features a barcode and indicates the product is prescription-only with a note 'NO VARNISH'.*
FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 60ct (Ranolazine 500mg 60tab)

Package Label – Ranolazine, 500mg Bottle, 60ct (Ranolazine 500mg 60tab)
Label for Ranolazine Extended-Release Tablets 500 mg by ScieGen Pharmaceuticals, Inc. The film-coated oral tablets come in a bottle of 60. The label includes storage instructions, dosage note, a barcode, and manufacturer details.*
FDA Label Image

Chemical Structure (Ranolazine Str)

Chemical Structure (Ranolazine Str)
Chemical structure of ranolazine, the active ingredient in RANOLAZINE tablets, shown as a structural formula diagram depicting its molecular components and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.